IRADIMED CORPORATION Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
IRADIMED CORPORATION (IRMD) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 55.36 thousand shares for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2022-03-04
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-09-30 was 41.12K shares, a 61.86% decline year-over-year.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-06-30 was 92.90K shares, a 18.57% increase year-over-year.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-03-31 was 99.81K shares, a 86.80% increase year-over-year.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-09-30 was 107.82K shares.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2019 was 55.36K shares, a 40.14% decline from fiscal 2018.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2018 was 92.49K shares.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2016 was 94.17K shares, a 23.53% decline from fiscal 2015.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2015 was 123.14K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2019-12-31 | 55.36K shares 10-K · filed 2022-03-04 | |||
| 2019-09-30 | 41.12K shares 10-Q · filed 2020-11-06 | 69.18K shares 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | 92.90K shares 10-Q · filed 2020-08-06 | 96.48K shares 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 99.81K shares 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 92.49K shares 10-K · filed 2021-03-05 | |||
| 2018-09-30 | 107.82K shares 10-Q · filed 2019-11-07 | 86.47K shares 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | 78.35K shares 10-Q · filed 2019-08-07 | 67.53K shares 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | 53.43K shares 10-Q · filed 2019-05-08 | |||
| 2017-06-30 | 8.62K shares 10-Q · filed 2018-08-08 | 15.71K shares 10-Q · filed 2018-08-08 | ||
| 2016-12-31 | 94.17K shares 10-K · filed 2019-03-07 | |||
| 2016-09-30 | 103.27K shares 10-Q · filed 2017-11-06 | 104.07K shares 10-Q · filed 2017-11-06 | ||
| 2016-06-30 | 102.28K shares 10-Q · filed 2017-08-04 | 104.82K shares 10-Q · filed 2017-08-04 | ||
| 2016-03-31 | 107.33K shares 10-Q · filed 2017-05-05 | |||
| 2015-12-31 | 123.14K shares 10-K · filed 2018-03-08 | |||
| 2015-09-30 | 133.09K shares 10-Q · filed 2016-11-04 | 115.60K shares 10-Q · filed 2016-11-04 | ||
| 2015-06-30 | 111.88K shares 10-Q · filed 2016-08-05 | 102.54K shares 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | 90.61K shares 10-Q · filed 2016-05-06 | |||
| 2014-09-30 | 847.00 shares 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |